{"id":1108,"date":"2016-01-05T16:53:06","date_gmt":"2016-01-05T21:53:06","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1108"},"modified":"2016-01-05T17:19:40","modified_gmt":"2016-01-05T22:19:40","slug":"secondaries-announced-1-05-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-1-05-2016\/","title":{"rendered":"Secondaries announced 1.05.2016"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n<p>Company: \tAdamas Pharmaceuticals, Inc.<br \/>\nSymbol: \tADMS<br \/>\nPrice: \t\tLast trade $27.91<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t2.5 million<br \/>\nUnderwriter(s) \tCowen &#038; Co., Piper Jaffray<br \/>\nCo Manager(s)\tWilliam Blair &#038; Co., JMP Securities, Trout Capital<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tCollegium Pharmaceutical, Inc.<br \/>\nSymbol: \tCOLL<br \/>\nPrice: \t\tLast trade $26.23<br \/>\nTrade Date: \t1\/8<br \/>\nShares: \t3.3 million<br \/>\nUnderwriter(s) \tJefferies, Piper Jaffray, William Blair, Needham, Janney Montgomery Scott<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tPioneer Natural<br \/>\nSymbol: \tPXD<br \/>\nPrice: \t\tLast trade $125.17<br \/>\nTrade Date: \t1\/6<br \/>\nShares: \t10.5 million<br \/>\nUnderwriter(s) \t BofA Merrill Lynch, Citigroup, Credit Suisse, J.P. Morgan<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tTherapeuticsMD<br \/>\nSymbol: \tTXMD<br \/>\nPrice: \t\tLast trade $9.30<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t13.44 million<br \/>\nUnderwriter(s) \tGoldman Sachs, Cowen &#038; Co., Stifel<br \/>\nCo Manager(s)\tGuggenheim Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tEpizyme, Inc.<br \/>\nSymbol: \tEPZM<br \/>\nPrice: \t\tLast trade $15.12<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t7.9 million<br \/>\nUnderwriter(s) \tCitigroup, Leerink Partners, RBC Capital Markets, JMP Securities, Wedbush PacGrow<br \/>\nCo Manager(s)\tMizuho Securities USA<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tProthena Corporation<br \/>\nSymbol: \tPRTA<br \/>\nPrice: \t\tLast trade $58.99<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t2.25 million<br \/>\nUnderwriter(s) \tRBC Capital Markets, UBS Investment Bank, Barclays<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tOtonomy, Inc.<br \/>\nSymbol: \tOTIC<br \/>\nPrice: \t\tLast trade $24.40<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t4 million<br \/>\nUnderwriter(s) \tBofA Merrill Lynch, Cowen &#038; Co., Piper Jaffray<br \/>\nCo Manager(s)\tSanford Bernstein, SunTrust Robinson Humphrey<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tAcadia Pharmaceuticals, Inc.<br \/>\nSymbol: \tACAD<br \/>\nPrice: \t\tLast trade $34.46<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t8.7 million<br \/>\nUnderwriter(s) \tBofA Merrill Lynch, J.P. Morgan<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tSage Therapeutics, Inc.<br \/>\nSymbol: \tSAGE<br \/>\nPrice: \t\tLast trade $56.51<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t2.65 million<br \/>\nUnderwriter(s) \tJ.P. Morgan, Goldman Sachs, Leerink Partner, Cowen &#038; Co<br \/>\nCo Manager(s)\tCanaccord Genuity<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tCempra Holdings<br \/>\nSymbol: \tCEMP<br \/>\nPrice: \t\tLast trade $28.73<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t6.09 million<br \/>\nUnderwriter(s) \tJ.P. Morgan, Jefferies<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: \tAcadia Healthcare<br \/>\nSymbol: \tACHC<br \/>\nPrice: \t\tLast trade $63.59<br \/>\nTrade Date: \t1\/7<br \/>\nShares: \t10 million<br \/>\nUnderwriter(s) \tBofA Merrill Lynch, Jefferies<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a>   <\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Adamas Pharmaceuticals, Inc. Symbol: ADMS Price: Last trade $27.91 Trade Date: 1\/7 Shares: 2.5 million Underwriter(s) Cowen &#038; Co., Piper Jaffray[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[732,369,729,733,346,224,50,291,730,310],"class_list":["post-1108","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-acad","tag-achc","tag-adms","tag-cemp","tag-coll","tag-epzm","tag-otic","tag-prta","tag-pxd","tag-sage"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1108"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1108\/revisions"}],"predecessor-version":[{"id":1110,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1108\/revisions\/1110"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}